2 hours ago · China
China still has ‘catching up to do’ to become biotech powerhouse, JPMorgan says

What's happening
SignalsMonitor is following this as a general story. South China Morning Post Asia is the outlet attached so far. The reports are tied to China. The first report grouped here was at 18 Nov 2026, 08:00 UTC. 2 material updates are listed in the timeline. The headline in use is “China still has ‘catching up to do’ to become biotech powerhouse, JPMorgan says”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
A lag in foundational research and looming geopolitical risks will weigh on China’s bid to build a world-class biotechnology innovation ecosystem, even as the sector’s overseas momentum remains strong, according to JPMorgan. “In China, there is still some catching up to do in basic research, particularly in biological and pharmaceutical…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by South China Morning Post Asia
China can become biotech powerhouse with more basic research, JPMorgan says
- Picked up by South China Morning Post Asia
China still has ‘catching up to do’ to become biotech powerhouse, JPMorgan says
Reported by 1 outlet
- South China Morning Post
- South China Morning PostChina can become biotech powerhouse with more basic research, JPMorgan says